J66213 Roxithromycin, 97%
SDS
| Stock No. | Größe | Preis ($) | Menge | Verfügbarkeit |
|---|---|---|---|---|
| J66213-06 | 5g | 61,20 |
|
|
| J66213-09 | 10g | 104,00 |
|
|
Roxithromycin, 97%
Chemische Eigenschaften
Anwendungen
Used to block bacterial protein synthesis. Clinically, used to treat respiratory tract, urinary and soft tissue infections.
Bemerkungen
Literaturverweise
Craig Knox et. al. DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Research, 2011,39D1035-D1041.
R N Jones; A L Barry; C Thornsberry. In vitro evaluation of three new macrolide antimicrobial agents, RU28965, RU29065, and RU29702, and comparisons with other orally administered drugs. Antimicrobial Agents and Chemotherapy, 1983,24(2), 209-215.
GHS Gefahren- und Sicherheitshinweise
Gefahrenhinweise (EU): H302
Harmful if swallowed.
Sicherheitshinweise: P264-P270-P301+P312a-P330-P501a
Wash thoroughly after handling. Do not eat, drink or smoke when using this product. IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. Dispose of contents/container in accordance with local/regional/national/international regulations.
Weitere Referenzen
Chemikalien
Life science
Metalle und Stoffe
Katalysatoren
